Literature DB >> 12160166

Cutaneous anthrax in Turkey: a review of 32 cases.

O Oncül1, M F Ozsoy, H C Gul, N Koçak, S Cavuslu, A Pahsa.   

Abstract

Anthrax, caused by the Gram-positive, rod-shaped, spore-forming bacterium Bacillus anthracis, is rarely seen in industrialized nations but is common in developing countries. Cutaneous anthrax accounts for 95% of cases and usually develops on exposed sites. This study reviews the clinical and laboratory findings of 32 patients diagnosed with cutaneous anthrax over a 4-y period in the eastern part of Turkey. All patients had a history of direct contact with infected animals. The patients, aged 6-72 y, comprised 17 (53%) males and 15 (47%) females. The most frequent localization site of skin lesions was the hands and fingers (31 patients), whereas the suborbital part of the face was invaded in 1 patient. The diagnosis was made as a result of typical clinical lesions, direct microscopy or bacterial isolation. All but 2 patients were successfully treated with penicillin; these other 2 patients were treated initially with sulbactam-ampicillin. All patients, including the patient with suborbital anthrax, were cured.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12160166     DOI: 10.1080/00365540110080610

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Recent outbreak of cutaneous anthrax in Bangladesh: clinico-demographic profile and treatment outcome of cases attended at Rajshahi Medical College Hospital.

Authors:  Muhammad Afsar Siddiqui; Md Azraf Hossain Khan; Sk Shamim Ahmed; Kazi Selim Anwar; Shaikh Md Akhtaruzzaman; Md Abdus Salam
Journal:  BMC Res Notes       Date:  2012-08-28

2.  Periocular cutaneous anthrax in Jimma Zone, Southwest Ethiopia: a case series.

Authors:  Yeshigeta Gelaw; Tsedeke Asaminew
Journal:  BMC Res Notes       Date:  2013-08-07

3.  Serum adenosine deaminase activity in cutaneous anthrax.

Authors:  Mahmut Sunnetcioglu; Sevdegul Karadas; Mehmet Aslan; Mehmet Resat Ceylan; Halit Demir; Mehmet Resit Oncu; Mustafa Kasım Karahocagil; Aysel Sunnetcioglu; Cenk Aypak
Journal:  Med Sci Monit       Date:  2014-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.